Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

趙毅 (Yee Chao)

[Profile]

  • Education
    • Ph.D., Institute of Clinical Medicine; National Yang-Ming University, Taipei, Taiwan, R.O.C.,
    • Bachelor of Medical Science, School of Medicine; Kaohsiung Medical College, Kaohsiung, Taiwan, R.O.C.,
  • Career and Experience
    Current Positions:
    • - Now, Professor, School of Medicine, National Yang-Ming University, Taipei, Taiwan, R.O.C.
    Experiences:
    • 2016- 2023, Director, Deparment of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • 2014- 2016, Chief, Environmental Health and Safety Office, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • 1998- 2014, Chief, Division of Chemoradiotherapy, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • 1990- 1998, Attending Physician, Gastroenterology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
  • Medical Expertise
    1. Gastric cancer, Hepatic cancer, Pancreatic cancer, GI tract tumors, Colorectal cancer, Esophageal cancer
  • License
    Taiwan License for General Medical Practice, The Board of Clinical Oncology of the Taiwan Clinical Oncology Society,

[Publications]

1. Hung YP, Chen MH, Lin JS, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP, Chao Y. The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients. J Chin Med Assoc. 2018 Jul;81(7):593-598.

2. Chen MH, Chang SC, Lin PC, Yang SH, Lin CC, Lan YT, Lin HH, Lin CH, Lai JI, Liang WY, Lu ML, Yang MH, Chao Y. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer. Oncologist. 2019;24(12):1534-1542.

3. Hung YP, Shao YY, Hsu C, Hsu CH, Lee JM, Yang MH, Chao Y. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. J Formos Med Assoc. 2020 :S0929-6646(20)30592-1.

4. Hung YP, Shao YY, Hsu C, Hsu CH, Lee JM, Yang MH, Chao Y. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. J Formos Med Assoc. 2021 Aug;120(8):1581-1590.

5. Yu HY, Li CP, Huang YH, Hsu SJ, Wang YP, Hsieh YC, Fang WL, Huang KH, Li AF, Lee RC, Lee KL, Wu YH, Lai IC, Yang WC, Hung YP, Wang YC, Chen SH, Chen MH, Chao Y. Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer. Cancers (Basel). 2022 Jan 3;14(1):218.

 

回到最上